Trial Identifier: | ACE-WM-001 |
Sponsor: | AcertaPharma |
NCTID:: | NCT02180724 |
Start Date: | September 2014 |
Primary Completion Date: | October 2019 |
Study Completion Date: | December 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
ES | Salamanca, ES, 37007 |
FR | Aurillac Cedex, FR, 15002 |
FR | Clermond Ferrand, FR, 63003 |
FR | Marseille CEDEX, FR, 13273 |
FR | Montpellier, FR, 34295 |
FR | Nantes, FR, 44093 |
FR | Paris, FR, 75015 |
FR | Paris cedex 13, FR, 75651 |
FR | Pierre Benite Cedex, FR, 69495 |
FR | Poitiers, FR, 86021 |
FR | Reims Cedex, FR, 51092 |
FR | Rennes Cedex, FR, 35000 |
FR | Toulouse Cedex, FR, 31059 |
FR | Vandoeuvre-les-Nancy, FR, 54500 |
GB | Bournemouth, GB, BH7 7DW |
GB | Leeds, GB, LS9 7TF |
GB | Leicester, GB, LE1 7RH |
GB | London, GB, SW3 6JJ |
GB | London, GB, NW1 2BU |
GB | Oxford, GB, OX3 7LE |
GB | Plymouth, GB, PL6 8DH |
GB | Southampton, GB, SO16 6YD |
GR | Athens, GR, 11528 |
IT | Bologna, IT, 40138 |
IT | Milan, IT, 20162 |
IT | Novara, IT, 28100 |
NL | Amsterdam, NL, 1105AZ |
NL | Utrecht, NL, 2508GA |
US, CA | Santa Barbara, CA, US, 93105 |
US, CO | Aurora, CO, US, 80012 |
US, DC | Washington DC, DC, US, 20007 |
US, MN | Minneapolis, MN, US, 55404 |
US, NY | New York, NY, US, 10021 |
US, TN | Nashville, TN, US, 37203 |
US, TX | Austin, TX, US, 78705 |
US, TX | Bedford, TX, US, 76022 |
US, TX | Houston, TX, US, 77030 |
US, WA | Vancouver, WA, US, 98684 |